Meta-Analysis of Effectiveness and Safety of Oral Anticoagulants in Atrial Fibrillation With Focus on Apixaban

Ying Bai; Shi Xubo; Changsheng Ma; Professor Gregory Lip

doi:10.1016/j.amjcard.2017.07.072

Related publications

Article2018

Effectiveness and Safety of Oral Anticoagulants Among Nonvalvular Atrial Fibrillation Patients

Professor Gregory Lip, Allison Keshishian, Xiaoyan Li, Melissa Hamilton, Cristina Masseria, Kiran Gupta, Xuemei Luo, Jack Mardekian, Keith Friend, Anagha Nadkarni, Xianying Pan, Onur Başer, Steven Deitelzweig

Article2019

Effectiveness and Safety of Contemporary Oral Anticoagulants Among Asians With Nonvalvular Atrial Fibrillation

So-Ryoung Lee, Eue-Keun Choi, Soonil Kwon, Kyungdo Han, Jin‐Hyung Jung, Myung‐Jin Cha, Seil Oh, Professor Gregory Lip

Article2020

Effectiveness and Safety of Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Diabetes Mellitus

Professor Gregory Lip, Allison Keshishian, Amiee Kang, Xiaoyan Li, Amol D. Dhamane, Xuemei Luo, Neeraja Balachander, Lisa Rosenblatt, Jack Mardekian, Anagha Nadkarni, Xianying Pan, Manuela Di Fusco, Alessandra Bassalobre García, Hüseyin Yüce, Steven Deitelzweig

Article2022

Effectiveness and Safety of Apixaban in over 3.9 Million People with Atrial Fibrillation: A Systematic Review and Meta-Analysis

Benjamin J. R. Buckley, Deirdre A. Lane, Peter Calvert, Juqian Zhang, David Gent, C. Daniel Mullins, Paul Dorian, Shun Kohsaka, Stefan H. Hohnloser, Professor Gregory Lip

Article2021

Effectiveness and Safety of Oral Anticoagulants Among Nonvalvular Atrial Fibrillation Patients With Active Cancer

Steven Deitelzweig, Allison Keshishian, Yan Zhang, Amiee Kang, Amol D. Dhamane, Xuemei Luo, Christian Klem, Mauricio Ferri, Jenny Jiang, Hüseyin Yüce, Professor Gregory Lip